High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.11, pp.2181-2188, 2004. ,
DOI : 10.1161/01.ATV.0000146325.93749.a8
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients, The Journal of Lipid Research, vol.43, issue.10, pp.1701-1708, 2002. ,
DOI : 10.1194/jlr.M200037-JLR200
Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.12, pp.2670-2676, 2000. ,
DOI : 10.1161/01.ATV.20.12.2670
Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1169, issue.3, pp.291-300, 1993. ,
DOI : 10.1016/0005-2760(93)90253-6
Pre-?? HDL: structure and metabolism, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1300, issue.2, pp.73-85, 1996. ,
DOI : 10.1016/0005-2760(95)00236-7
Characterization of human high-density lipoproteins by gradient gel electrophoresis, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.665, issue.3, pp.408-427, 1981. ,
DOI : 10.1016/0005-2760(81)90253-8
Formation of new HDL particles from lipid-free apolipoprotein A-I, J Lipid Res, vol.7, pp.1722-1754, 1996. ,
Unique Epitope of Apolipoprotein A-I Expressed in Pre-.beta.-1 High-Density Lipoprotein and Its Role in the Catalyzed Efflux of Cellular Cholesterol, Biochemistry, vol.33, issue.22, pp.6981-6986, 1994. ,
DOI : 10.1021/bi00188a030
Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects, Atherosclerosis, vol.171, issue.2, pp.287-93, 2003. ,
DOI : 10.1016/j.atherosclerosis.2003.08.011
Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release, The Journal of Lipid Research, vol.46, issue.7, pp.1457-65, 2005. ,
DOI : 10.1194/jlr.M400477-JLR200
Association of Coronary Heart Disease with Pre-??-HDL Concentrations in Japanese Men, Clinical Chemistry, vol.50, issue.3, pp.589-95, 2004. ,
DOI : 10.1373/clinchem.2003.029207
Quantitation of pre.beta.-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid, Biochemistry, vol.32, issue.19, pp.5025-5033, 1993. ,
DOI : 10.1021/bi00070a008
Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia, The American Journal of Cardiology, vol.95, issue.9, pp.1085-1093, 2005. ,
DOI : 10.1016/j.amjcard.2004.12.064
Interconversion between apolipoprotein A-Icontaining lipoproteins of pre-beta and alpha electrophoretic mobilities, J Lipid Res, vol.33, issue.12, pp.1807-1823, 1992. ,
Pre?? high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice, The Journal of Lipid Research, vol.45, issue.4, pp.716-744, 2004. ,
DOI : 10.1194/jlr.M300422-JLR200
ATP-binding cassette transporter AI and its role in HDL formation, Current Opinion in Lipidology, vol.16, issue.1, pp.19-25, 2005. ,
DOI : 10.1097/00041433-200502000-00005
Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins, J Lipid Res, vol.35, pp.1187-99, 1994. ,
Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity, Biochemistry, vol.31, issue.45, pp.11112-11119, 1992. ,
DOI : 10.1021/bi00160a022
Analytical performance of a sandwich enzyme immunoassay for prebeta1-HDL in stabilized plasma, The Journal of Lipid Research, vol.44, issue.3, pp.645-50, 2003. ,
DOI : 10.1194/jlr.D200025-JLR200
Bezafibrate Increases Pre??1-HDL at the Expense of HDL2b in Hypertriglyceridemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.11, pp.2428-2461, 2000. ,
DOI : 10.1161/01.ATV.20.11.2428
A new sandwich enzyme immunoassay for measurement of plasma pre-ß1-HDL levels, J Lipid Res, vol.41, pp.2083-2091, 2000. ,
Fat, Fit, and Leading the Charge: The Evolution of Measuring High-Density Lipoprotein Subpopulations, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.10, pp.2013-2018, 2005. ,
DOI : 10.1161/01.ATV.0000186043.86570.4f
HDL and arteriosclerosis: beyond reverse cholesterol transport, Atherosclerosis, vol.161, issue.1, pp.1-16, 2002. ,
DOI : 10.1016/S0021-9150(01)00651-7
Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender, J Lipid Res, vol.39, pp.670-678, 1998. ,
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits, Nature, vol.406, issue.6792, pp.203-210, 2000. ,
DOI : 10.1038/35018119
Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion, Atherosclerosis, vol.155, issue.2, pp.297-305, 2001. ,
DOI : 10.1016/S0021-9150(00)00568-2
Regulation of reverse cholesterol transport and clinical implications, The American Journal of Cardiology, vol.92, issue.4, pp.42-51, 2003. ,
DOI : 10.1016/S0002-9149(03)00615-5
Role of apolipoprotein A-I in the structure of human serum high density lipoproteins. Reconstitution studies, J Biol Chem, vol.252, issue.4, pp.1208-1224, 1977. ,
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.3, pp.421-429, 2004. ,
DOI : 10.1161/01.ATV.0000104029.74961.f5
High-density lipoprotein subclasses, Current Opinion in Lipidology, vol.5, issue.3, pp.241-248, 1994. ,
DOI : 10.1097/00041433-199405030-00013
Dynamics of reverse cholesterol transport: protection against atherosclerosis, Atherosclerosis, vol.161, issue.2, pp.245-54, 2002. ,
DOI : 10.1016/S0021-9150(01)00677-3
Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebetahigh density lipoprotein to alpha-high density lipoprotein, J Lipid Res, vol.41, issue.11, pp.1872-82, 2000. ,
Delineation of the Role of Pre-beta1-HDL in Cholesterol Efflux Using Isolated Pre-beta1-HDL, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.9, p.1482, 2002. ,
DOI : 10.1161/01.ATV.0000029120.44088.FE
Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies, Journal of Internal Medicine, vol.34, issue.1, pp.5-12, 1995. ,
DOI : 10.1111/j.1365-2796.1995.tb01133.x
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications., Proceedings of the National Academy of Sciences, vol.76, issue.9, pp.4350-4354, 1979. ,
DOI : 10.1073/pnas.76.9.4350
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.7, pp.1178-84, 2003. ,
DOI : 10.1161/01.ATV.0000075912.83860.26
High density lipoprotein cholesterol and mortality. The Framingham Heart Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.8, issue.6, pp.737-778, 1988. ,
DOI : 10.1161/01.ATV.8.6.737
Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties, Thromb Res, vol.121, issue.6, pp.865-71, 2008. ,
Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure, Journal of the American Society of Nephrology, vol.16, issue.11, pp.16-3381, 2005. ,
DOI : 10.1681/ASN.2005050535
The Role of Microparticles in Inflammation and Thrombosis, Scandinavian Journal of Immunology, vol.95, issue.1, pp.159-65, 2007. ,
DOI : 10.1046/j.1365-2141.2001.03101.x
Circulating Microparticles as Therapeutic Targets in Cardiovascular Diseases, Recent Patents on Cardiovascular Drug Discovery, vol.2, issue.1, pp.41-51, 2007. ,
DOI : 10.2174/157489007779606121
Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT), Atherosclerosis, vol.203, issue.2, pp.429-464, 2009. ,
DOI : 10.1016/j.atherosclerosis.2008.07.039
URL : https://hal.archives-ouvertes.fr/hal-00428378
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner, J Thromb Haemost, vol.1, issue.12, pp.2561-2569, 2003. ,
Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease, Hypertension, vol.48, issue.2, pp.180-186, 2006. ,
DOI : 10.1161/01.HYP.0000231507.00962.b5
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism, J Am Coll Cardiol, issue.9, pp.45-1467, 2005. ,
Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.12, pp.26-2775, 2006. ,
DOI : 10.1161/01.ATV.0000249639.36915.04
Circulating microparticles may influence early carotid artery remodeling, Journal of Hypertension, vol.28, issue.4, 2009. ,
DOI : 10.1097/HJH.0b013e328335d0a8
The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease, Nephrology Dialysis Transplantation, vol.24, issue.8, pp.24-2511, 2009. ,
DOI : 10.1093/ndt/gfp066
Detection and Measurement of Microparticles: An Evolving Research Tool for Vascular Biology, Seminars in Thrombosis and Hemostasis, vol.33, issue.8, pp.33-771, 2007. ,
DOI : 10.1055/s-2007-1000369
Formation of procoagulant microparticles and properties, Thrombosis Research, vol.125, pp.46-54 ,
DOI : 10.1016/j.thromres.2010.01.036
More on: measuring circulating cell-derived microparticles, Journal of Thrombosis and Haemostasis, vol.3, issue.3, pp.613-617, 2005. ,
DOI : 10.1016/j.molmed.2004.02.007
Circulating procoagulant microparticles in obesity, Diabetes & Metabolism, vol.32, issue.1, pp.82-87, 2006. ,
DOI : 10.1016/S1262-3636(07)70251-3
Apheresis-induced platelet activation:comparison of three types of cell separators, Transfusion, vol.6, issue.1, pp.182-192, 2000. ,
DOI : 10.1006/bcmd.1995.0025
How to detect and measure microparticles, Hematology Education: European Hematology Association, vol.4, pp.51-56, 2010. ,
The role of innate immunity in atherogenesis, J Lipid Res, p.50, 2009. ,
Endothelial microparticles as markers of endothelial dysfunction, Frontiers in Bioscience, vol.9, issue.1-3, pp.1118-1153, 2004. ,
DOI : 10.2741/1270
Membrane Microparticles: Two Sides of the Coin, Physiology, vol.20, issue.1, pp.22-29, 2005. ,
DOI : 10.1152/physiol.00029.2004
Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway*, Critical Care Medicine, vol.32, issue.3, pp.818-843, 2004. ,
DOI : 10.1097/01.CCM.0000114829.17746.19
Endothelial Microparticles (EMP) as Vascular Disease Markers, Adv Clin Chem, vol.39, pp.131-57, 2005. ,
DOI : 10.1016/S0065-2423(04)39005-0
Microparticle sizing by dynamic light scattering in fresh-frozen plasma, Vox Sanguinis, vol.51, issue.3, pp.206-218, 2009. ,
DOI : 10.1111/j.1423-0410.2008.01151.x
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques, J Am Coll Cardiol, vol.49, issue.7, pp.772-779, 2007. ,
CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization, J Am Coll Cardiol, issue.16, pp.52-1302, 2008. ,
Role of microparticles in atherothrombosis, Journal of Internal Medicine, vol.89, issue.5, pp.528-565, 2008. ,
DOI : 10.1046/j.1365-2141.2003.04716.x
Plasma microparticles and vascular disorders, British Journal of Haematology, vol.89, issue.1, pp.36-48, 2007. ,
DOI : 10.1016/S0049-3848(02)00354-7
The Role of Tissue Factor and Factor VIIa in Hemostasis, Anesthesia & Analgesia, vol.108, issue.5, pp.1447-52, 2009. ,
DOI : 10.1213/ane.0b013e31819bceb1
Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes, Circulation, vol.101, issue.8, pp.841-844, 2000. ,
DOI : 10.1161/01.CIR.101.8.841
Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.7, pp.25-1512, 2005. ,
DOI : 10.1161/01.ATV.0000170133.43608.37
Proteomics, Metabolomics, and Immunomics on Microparticles Derived From Human Atherosclerotic Plaques, Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques, pp.379-88, 2009. ,
DOI : 10.1161/CIRCGENETICS.108.842849
Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state, Thrombosis Research, vol.123, issue.6, pp.881-887, 2009. ,
DOI : 10.1016/j.thromres.2008.10.016
Human Platelets Secrete the Plasma Type of Platelet-Activating Factor Acetylhydrolase Primarily Associated With Microparticles, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.8, pp.26-1907, 2006. ,
DOI : 10.1161/01.ATV.0000228821.79588.ef
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists, Journal of Thrombosis and Haemostasis, vol.113, issue.7, pp.1118-1144, 2004. ,
DOI : 10.1111/j.1538-7836.2004.00805.x
Procoagulant Microparticles: ???Criminal Partners??? in Atherothrombosis and Deleterious Cellular Exchanges, Pathophysiology of Haemostasis and Thrombosis, vol.35, issue.1-2, pp.15-22, 2006. ,
DOI : 10.1159/000093538
Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection, J Heart Lung Transplant, vol.27, issue.1, pp.38-45, 2008. ,
Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients, Journal of Thrombosis and Thrombolysis, vol.61, issue.Suppl, pp.177-85, 2004. ,
DOI : 10.1007/s11239-005-0343-8
The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients, Platelets, vol.28, issue.1, pp.16-22, 2009. ,
DOI : 10.1016/S0021-9150(01)00433-6
Sources of Tissue Factor, Seminars in Thrombosis and Hemostasis, vol.32, issue.01, pp.11-23, 2006. ,
DOI : 10.1055/s-2006-933336
Physiopathologie de l???ath??roscl??rose et marqueurs pr??coces, Revue Francophone des Laboratoires, vol.2009, issue.409, pp.29-50, 2009. ,
DOI : 10.1016/S1773-035X(09)70199-6
Effects of severe hypertension on endothelial and platelet microparticles, Hypertension, issue.2, pp.41-211, 2003. ,
Role of Platelet Microparticles in the Production of Thromboxane by Rabbit Pulmonary Artery, Hypertension, vol.43, issue.2, pp.428-461, 2004. ,
DOI : 10.1161/01.HYP.0000110906.77479.91
Circulating microparticles: pathophysiology and clinical implications, Blood Reviews, vol.21, issue.3, pp.157-71, 2007. ,
DOI : 10.1016/j.blre.2006.09.001
Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles, Vox Sanguinis, vol.91, issue.2, pp.179-86, 2011. ,
DOI : 10.1111/j.1423-0410.2010.01385.x
Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity, Blood, vol.99, issue.11, pp.99-3962, 2002. ,
DOI : 10.1182/blood.V99.11.3962
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome, Journal of Thrombosis and Haemostasis, vol.25, issue.6, pp.1296-302, 2006. ,
DOI : 10.1074/jbc.M300351200
Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity, Arterioscler Thromb Vasc Biol, issue.12, pp.25-2522, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00129995
Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway, Biochemical and Biophysical Research Communications, vol.320, issue.1, pp.34-42, 2004. ,
DOI : 10.1016/j.bbrc.2004.05.127
Microparticles in cardiovascular diseases, Cardiovascular Research, vol.59, issue.2, pp.277-87, 2003. ,
DOI : 10.1016/S0008-6363(03)00367-5
Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.1, pp.112-118, 2006. ,
DOI : 10.1161/01.ATV.0000191634.13057.15
A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology, Heart, Lung and Circulation, vol.19, issue.7, pp.419-422, 2010. ,
DOI : 10.1016/j.hlc.2010.02.002
The Nature and Significance of Platelet Products in Human Plasma, British Journal of Haematology, vol.8, issue.3, pp.269-88, 1967. ,
DOI : 10.1136/jcp.6.1.34
A C-Reactive Protein Mutant That Does Not Bind to Phosphocholine and Pneumococcal C-Polysaccharide, The Journal of Immunology, vol.169, issue.6, pp.3217-3239, 2002. ,
DOI : 10.4049/jimmunol.169.6.3217
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death, Circulation, vol.105, issue.22, pp.105-2595, 2002. ,
DOI : 10.1161/01.CIR.0000017493.03108.1C
Lp(a) lipoprotein, vascular disease, and mortality in the elderly, N Engl J Med, issue.22, pp.349-2108, 2003. ,
Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes, New England Journal of Medicine, vol.345, issue.14, pp.345-1022, 2001. ,
DOI : 10.1056/NEJMoa003147
Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability, Circulation, vol.99, issue.7, pp.855-60, 1999. ,
DOI : 10.1161/01.CIR.99.7.855
Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events, Circulation, vol.99, issue.16, pp.99-2079, 1999. ,
DOI : 10.1161/01.CIR.99.16.2079
C-reactive protein and prognosis after percutaneous coronary intervention, European Heart Journal, vol.23, issue.12, pp.923-928, 2002. ,
DOI : 10.1053/euhj.2001.3130
High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.3, pp.387-91, 2004. ,
DOI : 10.1161/01.ATV.0000121505.88326.d2
Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.11, pp.23-2063, 2003. ,
DOI : 10.1161/01.ATV.0000084640.21712.9C
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet, Diabetes Care, vol.33, issue.5, pp.33-1134, 2010. ,
DOI : 10.2337/dc09-1765
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity ,
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids, Proceedings of the National Academy of Sciences, vol.99, issue.20, pp.99-13043, 2002. ,
DOI : 10.1073/pnas.192399699
High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis, J Rheumatol, issue.6, pp.31-1095, 2004. ,
Immunohistochemical Localization of Modified C-Reactive Protein Antigen in Normal Vascular Tissue, The American Journal of the Medical Sciences, vol.319, issue.2, pp.79-83, 2000. ,
DOI : 10.1016/S0002-9629(15)40692-5
[1] Introduction to the plasma lipoproteins, Methods Enzymol, vol.128, pp.3-41, 1986. ,
DOI : 10.1016/0076-6879(86)28061-1
L???hyperhomocyst??in??mie : facteur de risque cardiovasculaire ou simple marqueur ?, Pathologie Biologie, vol.51, issue.2, pp.111-132, 2003. ,
DOI : 10.1016/S0369-8114(03)00105-6
Homocysteine and atherothrombosis: Diagnosis and treatment, Current Atherosclerosis Reports, vol.288, issue.4 ,
DOI : 10.1007/s11883-003-0050-x
Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method, Pathology International, vol.367, issue.9, pp.45-635, 1995. ,
DOI : 10.1111/j.1440-1827.1995.tb03515.x
Lack of specific receptors for Creactive protein on white blood cells, Eur J Immunol, issue.12, pp.31-3475, 2001. ,
Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin, Circulation, vol.100, issue.8, pp.793-801, 1999. ,
DOI : 10.1161/01.CIR.100.8.793
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome, American Heart Journal, vol.141, issue.2, pp.211-218, 2001. ,
DOI : 10.1067/mhj.2001.112238
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study, Diabetes, vol.49, issue.3, pp.485-91, 2000. ,
DOI : 10.2337/diabetes.49.3.485
Coronary Artery Disease and Infection with Chlamydia Pneumonia., Japanese Heart Journal, vol.41, issue.2, pp.165-72, 2000. ,
DOI : 10.1536/jhj.41.165
Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes, Journal of the American College of Cardiology, vol.32, issue.2, pp.368-72, 1998. ,
DOI : 10.1016/S0735-1097(98)00250-2
Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein, International Journal of Cardiology, vol.98, issue.2, pp.199-206, 2005. ,
DOI : 10.1016/j.ijcard.2004.05.019
C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon?, Circulation, vol.100, issue.1, pp.96-102, 1999. ,
DOI : 10.1161/01.CIR.100.1.96
C-Reactive Protein Upregulates Complement-Inhibitory Factors in Endothelial Cells, Circulation, vol.109, issue.7, pp.833-839, 2004. ,
DOI : 10.1161/01.CIR.0000117087.27524.0E
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina, New England Journal of Medicine, vol.331, issue.7, pp.331-417, 1994. ,
DOI : 10.1056/NEJM199408183310701
Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis, Clinical Chemistry and Laboratory Medicine, vol.39, issue.5, pp.380-384, 2001. ,
DOI : 10.1515/CCLM.2001.060
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group, N Engl J Med, issue.16, pp.343-1148, 2000. ,
C-Reactive Protein, Int Rev Exp Pathol, vol.27, pp.83-111, 1985. ,
DOI : 10.1006/rwei.1999.0175
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention, Circulation, vol.107, issue.3, pp.363-372, 2003. ,
DOI : 10.1161/01.CIR.0000053730.47739.3C
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events, New England Journal of Medicine, vol.347, issue.20, pp.347-1557, 2002. ,
DOI : 10.1056/NEJMoa021993
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, New England Journal of Medicine, vol.342, issue.12, pp.342-836, 2000. ,
DOI : 10.1056/NEJM200003233421202
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women, Circulation, vol.107, issue.3, pp.391-398, 2003. ,
DOI : 10.1161/01.CIR.0000055014.62083.05
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events, Circulation, vol.109, issue.25_suppl_1, pp.6-19, 2004. ,
DOI : 10.1161/01.CIR.0000133444.17867.56
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men, Circulation, vol.101, issue.15, pp.1767-72, 2000. ,
DOI : 10.1161/01.CIR.101.15.1767
Plasma Homocysteine Concentration, Statin Therapy, and the Risk of First Acute Coronary Events, Circulation, vol.105, issue.15, pp.1776-1785, 2002. ,
DOI : 10.1161/01.CIR.0000014447.06099.FB
Inflammatory Biomarkers, Statins, and the Risk of Stroke: Cracking a Clinical Conundrum, Circulation, vol.105, issue.22, pp.2583-2588, 2002. ,
DOI : 10.1161/01.CIR.0000017822.82512.62
Soluble P-Selectin and the Risk of Future Cardiovascular Events, Circulation, vol.103, issue.4, pp.491-496, 2001. ,
DOI : 10.1161/01.CIR.103.4.491
Novel Risk Factors for Systemic Atherosclerosis, JAMA, vol.285, issue.19, pp.285-2481, 2001. ,
DOI : 10.1001/jama.285.19.2481
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease, Clin Chem, issue.3, pp.47-403, 2001. ,
Interactions of C-reactive protein with the complement system. II. C- reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations, Journal of Experimental Medicine, vol.142, issue.3, pp.709-730, 1975. ,
DOI : 10.1084/jem.142.3.709
Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina, J Thromb Thrombolysis, issue.93, pp.217-239, 2000. ,
Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene, Genes and Immunity, vol.3, issue.1, pp.14-23, 2002. ,
DOI : 10.1038/sj.gene.6363820
Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein, Biochemical Journal, vol.367, issue.2, pp.367-403, 2002. ,
DOI : 10.1042/bj20020492
The physiological structure of human C-reactive protein and its complex with phosphocholine, Structure, vol.7, issue.2, pp.169-77, 1999. ,
DOI : 10.1016/S0969-2126(99)80023-9
C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.18, issue.9, pp.1386-92, 1998. ,
DOI : 10.1161/01.ATV.18.9.1386
LDL receptor-independent and -dependent uptake of lipoproteins, Atherosclerosis, vol.118, pp.43-50, 1995. ,
DOI : 10.1016/0021-9150(95)90072-1
C-Reactive Protein: Structure Affects Function, Circulation, vol.109, issue.16, pp.1914-1921, 2004. ,
DOI : 10.1161/01.CIR.0000127085.32999.64
Human C-reactive protein: expression, structure, and function, Molecular Immunology, vol.38, issue.2-3, pp.189-97, 2001. ,
DOI : 10.1016/S0161-5890(01)00042-6
Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients, Clinical Biochemistry, vol.44, issue.4, pp.342-344, 2011. ,
DOI : 10.1016/j.clinbiochem.2010.12.004
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component, J Biol Chem, issue.24, pp.260-13384, 1985. ,
Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques, The American Journal of Pathology, vol.158, issue.3, pp.1039-51, 2001. ,
DOI : 10.1016/S0002-9440(10)64051-5
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis, Atherosclerosis, vol.162, issue.1, pp.217-226, 2002. ,
DOI : 10.1016/S0021-9150(01)00703-1
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes, New England Journal of Medicine, vol.358, issue.20, pp.358-2107, 2008. ,
DOI : 10.1056/NEJMoa0707064
Coronary C-reactive protein distribution: its relation to development of atherosclerosis, Atherosclerosis, vol.145, issue.2, pp.375-384, 1999. ,
DOI : 10.1016/S0021-9150(99)00105-7